Summit Securities Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.2K Buy
+238
New +$21.1K ﹤0.01% 505
2024
Q4
Sell
-66
Closed -$7K 606
2024
Q3
$7K Buy
+66
New +$7.72K ﹤0.01% 403
2024
Q1
Sell
-718
Closed -$93K 417
2023
Q4
$93K Buy
+718
New +$99K 0.01% 343
2014
Q4
Sell
-375
Closed -$3K 590
2014
Q3
$3K Buy
+375
New +$2.82K ﹤0.01% 590

Other funds holding ACLS

Summit Securities Group's ACLS Position: Q1 2026 in Review

Summit Securities Group opened a new position in Axcelis (ACLS) in Q1 2026: 238 shares worth $22.2K. The stake represents ﹤0.01% of the portfolio and ranks #505 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in ACLS as recently as Q3 2024.

Summit Securities Group first reported a position in ACLS in Q3 2014 and has held it in 4 quarters since. The position peaked at $93K in Q4 2023. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Summit Securities Group held 238 shares of Axcelis worth $22.2K as of Q1 2026.
  • Axcelis was a new Summit Securities Group position in Q1 2026.
  • Axcelis made up ﹤0.01% of Summit Securities Group's portfolio in Q1 2026, its #505 holding.
  • Summit Securities Group first reported a position in Axcelis in Q3 2014 and has held it in 4 quarters since.
  • Summit Securities Group's Axcelis position peaked at $93K in Q4 2023.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Summit Securities Group's 13F filing for Q1 2026, filed 30 Apr 2026.